BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Job Trends

  Ascent Partners with Renaissance Periodization

  Ascent, a sports nutrition company committed to providing clean and pure performance products to athletes, is now the Official Performance Nutrition Partner of Renaissance Periodization (RP)

  January 3, 2019

   · 

  2 min read
• Business

  Renowned reproductive expert, Nicole Noyes, MD, to lead Northwell fertility services

  Nicole Noyes, MD, a fertility preservation and in vitro fertilization specialist, assumed her new role on January 1 as Northwell Health’s system chief for reproductive endocrinology and infertility.

  January 3, 2019

   · 

  3 min read
• Genetown

  Infinity To Present At 37th Annual J.P. Morgan Healthcare Conference

  Infinity Pharmaceuticals Inc. (NASDAQ: INFI) will be presenting at the 37th Annual J.P. Morgan Healthcare Conference on Thursday, January 10, 2019, at 9:30 a.m. PST (12:30 p.m. EST) in San Francisco, CA.

  January 3, 2019

   · 

  1 min read
• Biotech Bay

  Sutro to Present at 37th Annual J.P. Morgan Healthcare Conference

  Sutro Biopharma, Inc. today announced that Bill Newell, Chief Executive Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference on Thursday, Jan. 10, 2019 at 11:30 a.m. PT / 2:30 p.m. ET at the Westin St. Francis Hotel in San Francisco.

  January 3, 2019

   · 

  4 min read
• Pharm Country

  SCYNEXIS Provides Year-end Update and Outlines Plans for 2019

  Initiated VANISH Phase 3 program of oral ibrexafungerp in acute VVC; top-line data expected in 1H 2020 with potential NDA filing in 2H 2020

  January 3, 2019

   · 

  7 min read
• Biotech Bay

  Verily Announces $1 Billion Investment Round to Fund Growth and Innovation

  Verily, an Alphabet company, today announced a $1 billion investment round, led by Silver Lake, as it advances plans on business strategies that are additive and complementary to its current life sciences portfolio.

  January 3, 2019

   · 

  2 min read
• Pharm Country

  BioNJ’s 26th Annual Dinner Meeting & Innovation Celebration to Honor New Jersey’s Innovators and the Patients and Advocates Who Inspire Them

  Considered the kickoff event of the year for the life sciences industry, BioNJ’s 26th Annual Dinner Meeting & Innovation Celebration will take place Thursday, February 7, 2019 at the Hilton East Brunswick.

  January 3, 2019

   · 

  2 min read